4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide

CAS: 284461-73-0

Ref. AN-AG0039KS

Produktinformation

• Name: 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
• Synonyme: [u'4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxylic acid methyamide-4-methylbenzenesulfonate', u'BAY 43 9006', u'BAY 43-9006', u'BAY 439006', u'BAY 545 9085', u'BAY 545-9085', u'BAY 5459085', u'BAY 673472', u'BAY-545-9085', u'BAY-673472', u'BAY5459085', u'Nexavar', u'sorafenib', u'Sorafenib N Oxide', u'sorafenib N-oxide', u'sorafenib tosylate', u'Sorafenib', u'284461-73-0', u'Nexavar', u'BAY 43-9006', u'4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide', u'UNII-9ZOQ3TZI87', u'4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N-METHYLPICOLINAMIDE', u'4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide', u"N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea", u'9ZOQ3TZI87', u'CHEMBL1336', u'4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide', u'4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE', u'CHEBI:50924', u'Sorafenib-d3', u'MFCD06411450', u'2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-', u'BAY-43-9006', u'Sorafenib (Nexavar)', u'Sorafenib [INN]', u'4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide', u'sorafenibum', u'2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-', u'BAX', u'NSC-724772', u'BAY-54-9085', u'NCGC00167488-01', u'Sorafinib', u'Sorafenib [USAN:INN:BAN]', u'SR-00000000529', u'HSDB 8173', u'1uwh', u'3gcs', u'3heg', u'4asd', u'Hit compound, 8', u'Sorafenib, 4', u'BAY 439006', u'BAY43-9006', u'Kinome_766', u'SORAFENIB BASE', u'Sorafenib (USAN/INN)', u'Nexavar (TN) (Bayer)', u'EC 608-209-4', u'AC1L50CF', u'SCHEMBL8218', u'4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate', u'cid_216239', u'GTPL5711', u'QCR-65', u'DTXSID7041128', u'BDBM16673', u'Nexavar|||BAY 43-9006', u'SYN1082', u'MLDQJTXFUGDVEO-UHFFFAOYSA-N', u'BCPP000064', u'HMS2043A18', u'HMS3244A15', u'HMS3244A16', u'HMS3244B15', u'HMS3656N20', u'K00597a', u'ACT06732', u'AOB87782', u'BCP01767', u'ZINC1493878', u'AN-613', u'BAY439006', u'CS0056', u'NSC747971', u'RS0103', u's7397', u'STK627350', u'AKOS005560229', u'AC-1674', u'ACN-032355', u'CS-1590', u'DB00398', u'MCULE-6112506696', u'NSC-747971', u'PB14443', u'SB19942', u'SF-0529', u'BAY-43-0006', u'KS-0000009E', u'Sorafenib free base (BAY-43-9006)', u'NCGC00167488-02', u'NCGC00167488-03', u'NCGC00167488-04', u'NCGC00167488-05', u'NCGC00167488-07', u'NCGC00167488-14', u'100012-18-8', u'4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide', u'AK163019', u'BC679588', u'EN002709', u'HY-10201', u"N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea", u'SC-19355', u'AB0019677', u'AB1004622', u'LS-186067', u'LS-187021', u'LS-187788', u'AM20090614', u'FT-0650736', u'SW202562-4', u'D08524', u'J10391', u'15216-EP2272827A1', u'15216-EP2298778A1'], 2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-, 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide, 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide 4-methylbenzenesulfonate, 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-Pyridinecarboxamide, Bay 43-9006, N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea, Nevaxar, Sorafenib base
• CAS: 284461-73-0
• Marke: Indagoo

Chemische Eigenschaften

• Molekulargewicht: 464.8249
• Formel: C₂₁H₁₆ClF₃N₄O₃
• Reinheit: 99%
• Farbe/Form: Solid
• InChl: InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)
• InChI Key: MLDQJTXFUGDVEO-UHFFFAOYSA-N